Dynamic contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: Evaluation in a rat rhabdomyosarcoma model

European Radiology

Volumn 19, Issue 11, 2009, Pages 2663-2671

  De Keyzer, Frederik ^a   Vandecaveye, V ^a   Thoeny, H ^b   Chen, F ^a   Ni, Y ^a   Marchal, G ^a   Hermans, R ^a   Nuyts, S ^a   Landuyt, W ^c   Bosmans, H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Diffusion weighted MRI; Dynamic contrast enhanced MRI; Experimental tumor model; Necrosis; Radiotherapy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; RAT; RHABDOMYOSARCOMA; TISSUE PERFUSION; TREATMENT DURATION; TUMOR NECROSIS;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; DOSE FRACTIONATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NECROSIS; NEOPLASM TRANSPLANTATION; PERFUSION; RADIOTHERAPY; RATS; RHABDOMYOSARCOMA;

EID: 70350164590     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1451-1     Document Type: Article

References (22)

1. Senan S, Smit EF (2007) Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 12:465-477
2. Hartsell WF, Scott CB, Bruner DW et al (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97:798-804
3. Onimaru R, Fujino M, Yamazaki K et al (2007) Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 70:374-381
4. Stroobants S, Goeminne J, Seegers M et al (2003) 18FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 39:2012-2020
5. Grégoire V, Bol A, Geets X et al (2006) Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. Semin Radiat Oncol 16:232-238
6. Le Bihan D (1995) Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 8:375-386
7. Padhani AR, Husband JE (2001) Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 56:607-620
8. Thoeny HC, De Keyzer F, Chen F et al (2005) Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 234:756-764
9. Mayr NA, Magnotta VA, Ehrhardt JC et al (1996) Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 35:915-924
10. Allen SD, Padhani AR, Dzik-Jurasz AS et al (2007) Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. Am J Radiol 188:442-451
11. Hatano K, Sekiya Y, Araki H et al (1999) Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 45:639-644
12. van de Bunt L, van der Heide UA, Ketelaars M et al (2006) Conventional, conformal and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. Int J Radiat Oncol Biol Phys 64:189-196
13. Thoeny HC, De Keyzer F, Chen F et al (2005) Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin A-4 phosphate after repeated administration. Neoplasia 7:779-787
14. Seierstad T, Folkvord S, Roe K et al (2007) Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice. Neoplasia 9:392-400
15. Chenevert TL, McKeever PE, Ross BD (1997) Monitoring of early response of experimental brain tumors to therapy using diffusion MRI. Clin Cancer Res 3:1457-1466
16. Stegman LD, Rehemtulla A, Hamstra DA et al (2000) Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther 7:1005-1010
17. Mardor Y, Pfeffer R, Spiegelmann R (2003) Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21:1094-1100
18. Tomura N, Narita K, Izumi J et al (2006) Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response. J Comput Assist Tomogr 30:496-500
19. Thoeny HC, De Keyzer F, Vandecaveye V et al (2005) Effect of vascular targeting agent in rat tumor model: Dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 237:492-499
20. Ceelen W, Smeets P, Backes W et al (2006) Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model. Int J Radiat Oncol Biol Phys 64:1188-1196
21. Kobayashi H, Reijnders K, English S et al (2004) Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation. Clin Cancer Res 10:7712-7720
22. Horsman MR, Nielsen T, Ostergaard L et al (2006) Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response. Acta Oncol 45:876-880